Remote Close-Out Visits in Clinical Trials: Pros and Cons
Remote Close-Out Visits in Clinical Trials: Advantages, Limitations, and Best Practices The shift to digital operations during the COVID-19 pandemic rapidly accelerated the adoption of remote processes across the pharmaceutical and clinical research industry. One such adaptation was the rise of Remote Close-Out Visits (COVs)—an alternative to traditional on-site visits conducted by Clinical Research Associates…
Read More “Remote Close-Out Visits in Clinical Trials: Pros and Cons” »